10X Genomics

10X Genomics R&D per Employee

The R&D Spending per Employee of 10X Genomics (TXG) as of Nov 6, 2026 is 202,573.85 USD. In the previous year, R&D Spending per Employee was 224,701.19 USD — a change of -9.85% (lower).

R&D per Employee

202,573.85USD

YoY

-9.85%

Last updated:

R&D Spending per Employee of 10X Genomics is 2025 202,573.85 USD. R&D Spending per Employee of 10X Genomics was 2024 224,701.19 USD. It decreases by -9.85% lower compared to the previous year.

The 10X Genomics R&D per Employee history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D per Employee
Date
R&D per Employee
Jan 1, 2018
40,353.99 USD
Jan 1, 2019
70,540.75 USD
Jan 1, 2020
104,732.60 USD
Jan 1, 2021
179,755.52 USD
Jan 1, 2022
225,523.77 USD
Jan 1, 2023
229,483.87 USD
Jan 1, 2024
224,701.19 USD
Jan 1, 2025
202,573.85 USD
The 10X Genomics R&D per Employee history
YEARR&D per EmployeeYoY
202,573.85USD-9.85%
224,701.19USD-2.08%
229,483.87USD+1.76%
225,523.77USD+25.46%
179,755.52USD+71.63%
104,732.60USD+48.47%
70,540.75USD+74.80%
40,353.99USD+47.80%
27,303.90USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

10X Genomics Stock analysis

What does 10X Genomics do? 10X Genomics is a US-based company specializing in the development of life science products. It was founded in 2012 by Serge Saxonov and Ben Hindson and is headquartered in Pleasanton, California. The company's business model focuses on providing technology platforms that enable researchers and scientists to analyze and understand complex biological data. It combines microfluidics, genomics, and bioinformatics. 10X Genomics is divided into different divisions, each focusing on different products and applications: Single-Cell Genomics, Long-Read Sequencing, Immune Profiling, and Spatial Transcriptomics. The company's products include the Chromium platform for cell type identification, disease research, and drug screening; Long-Read Sequencing technology for reading larger DNA fragments; tools and solutions for immune profiling and understanding the immune system; and Spatial Transcriptomics technology for studying the spatial organization of gene expression in tissues. 10X Genomics also offers other products and solutions in the field of genomic sequencing and analysis, including DNA preparation and sequencing kits, software for DNA data analysis and interpretation, and consulting and training services. The company has received various awards and recognition for its innovative approach, including the Innovation Award from The Scientist magazine and the Disruptive Technology Award from the Wall Street Journal. Overall, 10X Genomics has become a leading company in the life science industry, contributing to the advancement of scientific understanding and supporting progress in medicine and biotechnology. 10X Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 10X Genomics stock

R&D Spending per Employee of 10X Genomics is 202,573.85 USD in 2025.

R&D Spending per Employee of 10X Genomics changed from 224,701.19 USD to 202,573.85 USD, representing a -9.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of R&D Spending per Employee 10X Genomics since 2006 – with annual values, charts, and detailed analysis.

R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.

R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's 10X Genomics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — 10X Genomics

All Key Metrics — 10X Genomics